308 related articles for article (PubMed ID: 36150104)
1. Suppression of vacuolar-type ATPase and induction of endoplasmic reticulum stress by proton pump inhibitors.
Lee WP
J Chin Med Assoc; 2022 Sep; 85(9):915-921. PubMed ID: 36150104
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy.
Liu ZW; Zhu HT; Chen KL; Dong X; Wei J; Qiu C; Xue JH
Cardiovasc Diabetol; 2013 Nov; 12():158. PubMed ID: 24180212
[TBL] [Abstract][Full Text] [Related]
3. [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].
de Korwin JD; Ducrotté P; Vallot T
Presse Med; 2004 Jun; 33(11):746-54. PubMed ID: 15257232
[TBL] [Abstract][Full Text] [Related]
4. Enhanced lysosomal activity is involved in Bax inhibitor-1-induced regulation of the endoplasmic reticulum (ER) stress response and cell death against ER stress: involvement of vacuolar H+-ATPase (V-ATPase).
Lee GH; Kim DS; Kim HT; Lee JW; Chung CH; Ahn T; Lim JM; Kim IK; Chae HJ; Kim HR
J Biol Chem; 2011 Jul; 286(28):24743-53. PubMed ID: 21586565
[TBL] [Abstract][Full Text] [Related]
5. Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Eur J Intern Med; 2019 Jan; 59():65-69. PubMed ID: 30154038
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor EB protects against endoplasmic reticulum stress in human coronary artery endothelial cells.
Haas MJ; Feng V; Gonzales K; Bikkina P; Angelica Landicho M; Mooradian AD
Eur J Pharmacol; 2022 Oct; 933():175274. PubMed ID: 36108736
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors may reduce tumour resistance.
De Milito A; Fais S
Expert Opin Pharmacother; 2005 Jun; 6(7):1049-54. PubMed ID: 15957961
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitors and Bone Health: An Update Narrative Review.
Lespessailles E; Toumi H
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142643
[TBL] [Abstract][Full Text] [Related]
9. Non-Structural Protein 2B of Human Rhinovirus 16 Activates Both PERK and ATF6 Rather Than IRE1 to Trigger ER Stress.
Song J; Chi M; Luo X; Song Q; Xia D; Shi B; Han J
Viruses; 2019 Feb; 11(2):. PubMed ID: 30717233
[TBL] [Abstract][Full Text] [Related]
10. ER stress signaling has an activating transcription factor 6α (ATF6)-dependent "off-switch".
Walter F; O'Brien A; Concannon CG; Düssmann H; Prehn JHM
J Biol Chem; 2018 Nov; 293(47):18270-18284. PubMed ID: 30287689
[TBL] [Abstract][Full Text] [Related]
11. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
Park CH; Kim EH; Roh YH; Kim HY; Lee SK
PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
Zvyaga T; Chang SY; Chen C; Yang Z; Vuppugalla R; Hurley J; Thorndike D; Wagner A; Chimalakonda A; Rodrigues AD
Drug Metab Dispos; 2012 Sep; 40(9):1698-711. PubMed ID: 22648560
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning with endoplasmic reticulum stress alleviated heart ischemia/reperfusion injury via modulating IRE1/ATF6/RACK1/PERK and PGC-1α in diabetes mellitus.
Yan B; Liu S; Li X; Zhong Y; Tong F; Yang S
Biomed Pharmacother; 2019 Oct; 118():109407. PubMed ID: 31545290
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer.
Song T; Jeon HK; Hong JE; Choi JJ; Kim TJ; Choi CH; Bae DS; Kim BG; Lee JW
Cancer Res Treat; 2017 Jul; 49(3):595-606. PubMed ID: 27669706
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.
Abed MN; Alassaf FA; Jasim MHM; Alfahad M; Qazzaz ME
Pharmacology; 2020; 105(11-12):645-651. PubMed ID: 32289807
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.
Robinson M; Horn J
Drugs; 2003; 63(24):2739-54. PubMed ID: 14664653
[TBL] [Abstract][Full Text] [Related]
18. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Li XQ; Andersson TB; Ahlström M; Weidolf L
Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress promotes macrophage-derived foam cell formation by up-regulating cluster of differentiation 36 (CD36) expression.
Yao S; Miao C; Tian H; Sang H; Yang N; Jiao P; Han J; Zong C; Qin S
J Biol Chem; 2014 Feb; 289(7):4032-42. PubMed ID: 24366867
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus B3 Infection Triggers Autophagy through 3 Pathways of Endoplasmic Reticulum Stress.
Luo XN; Yao HL; Song J; Song QQ; Shi BT; Xia D; Han J
Biomed Environ Sci; 2018 Dec; 31(12):867-875. PubMed ID: 30636656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
